WallachBeth Capital
WallachBeth Capital is a privately held, FINRA-registered broker-dealer that provides agency-only institutional execution, consulting, and capital markets services to asset managers, hedge funds, and small-to-mid-cap healthcare/biotech issuers, with over $1.5 billion raised for clients since 2014.
- Company typePrivate
- Founded2014
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What WallachBeth Capital does
WallachBeth Capital is a privately held, FINRA-registered broker-dealer founded in 2014 and headquartered in Jersey City, NJ with an additional office in Boca Raton, FL. The firm operates on a fully disclosed, agency-only basis across three integrated service lines: Execution Services (custom execution in equities, ETFs, and derivatives, including risk-market liquidity sourcing, creation/redemption baskets, high-touch program trading, NAV markets, and algorithmic venues, plus outsourced trading for asset managers); Consulting Services (risk management, portfolio solutions, execution consulting, and bespoke market intelligence); and Capital Markets (IPOs, registered direct offerings, PIPEs, private placements, bridge financing, and financial advisory, with a stated track record of over $1.5 billion in equity and debt capital raised for clients). The firm does not own an ATS or operate a principal market-making desk, which is the structural source of its "no conflicts" positioning.
The platform's underlying technology stack comprises an internal proprietary electronic trading platform (Phase I rolled out in 2020) and a comprehensive algorithm suite leveraging partner-provided technology, with no disclosed in-house AI/ML capabilities. Revenue is generated via transaction-based execution fees, capital markets placement and underwriting fees, and professional-services consulting fees, with pricing not publicly disclosed and negotiated on a relationship basis. Distribution is direct via sales-led, enterprise-style relationship management rather than through reseller or platform channels.
WallachBeth serves two primary customer segments: (1) institutional investors — asset managers, hedge funds, and financial institutions — that require agency execution, derivatives facilitation, and outsourced trading; and (2) small-to-mid-cap innovative companies in biotech, pharmaceutical, medtech, diagnostic, and telehealth that need capital markets and investment banking expertise. A separate Financial Services and FinTech vertical was established in 2018 under Managing Director Dave Mortimer. The firm also maintains ecosystem marketing through its annual Park City Symposium, financial media appearances on CNBC and Bloomberg, and industry event sponsorships.
WallachBeth Capital firmographics
Firmographics- Name
- WallachBeth Capital
- Legal name
- WallachBeth Capital, LLC
- Website
- https://wallachbeth.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- WallachBeth Capital is a privately held, FINRA-registered broker-dealer that provides agency-only institutional execution, consulting, and capital markets services to asset managers, hedge funds, and small-to-mid-cap healthcare/biotech issuers, with over $1.5 billion raised for clients since 2014.
- Ownership category
- akta.pro rank
WallachBeth Capital industry classification
Industry- Product category
- Institutional Brokerage & Capital Markets
- NAICS
- Investment Banking and Securities Intermediation (523150), Investment Banking and Securities Intermediation (52315), Portfolio Management and Investment Advice (52394)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
- akta.pro primary industry
- Agency Equity Execution (Cash Equities) (FSACAFAA)
- akta.pro secondary industries
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC), Prime Brokerage Financing (Margin/Stock Loan) (FSACAIAD)
Keywords
Where WallachBeth Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
WallachBeth Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Capital Markets and Investment Banking Services: Fees earned from capital raising activities including IPOs, registered direct offerings, follow-on offerings, PIPE offerings, private placements, uplisting transactions, bridge financing, and financial advisory for small to medium-sized healthcare and biotech companies. WallachBeth has helped companies raise over $1.5 billion in equity and debt capital.
- Institutional Execution Services: Agency-based execution services for equities, ETFs, and derivatives. Operating on fully disclosed, agency-only basis providing execution strategies, consulting, and outsourced trading capabilities to institutional clients.
- Consulting Services: Consultative services including risk management, portfolio solutions, execution consulting, and intelligence. Services are asset and security-type agnostic.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
WallachBeth Capital product offering
Product offeringCore offering
WallachBeth Capital is a boutique institutional broker-dealer providing execution, consulting, and capital markets services on a fully disclosed, agency-only basis. Its Execution practice delivers equities, ETF, and derivatives execution with algorithmic and outsourced trading capabilities for asset managers and hedge funds. Its Capital Markets practice provides investment banking services — IPOs, registered direct offerings, PIPE offerings, private placements, uplistings, bridge financing, and financial advisory — focused on small-to-mid-cap healthcare and biotech issuers, with over $1.5 billion in client capital raised.
Product overview
WallachBeth Capital is a leading provider of institutional execution services offering a unified platform of Execution, Consulting, and Capital Markets services. The Execution Services core product includes Equities & ETFs, Derivatives, Electronic Trading, and Outsourced Trading sub-products that help institutions navigate complex markets on an agency-only basis. The Consulting Services encompass Risk Management, Portfolio Solutions, Execution Consulting, and Intelligence offerings. The Capital Markets division provides investment banking services including IPOs, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, having helped companies raise over $1.5 billion in Equity and Debt Capital, with a specialty focus on small to medium-sized innovative Biotech/Pharmaceutical/Medtech/Diagnostic/Telehealth companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Execution Services Institutional execution solutions spanning equities, ETFs, and derivatives, including Equities & ETFs (risk markets, creation/redemption baskets, high-touch program trading, NAV markets, algorithmic venues), Derivatives (Delta One listed and OTC products), Electronic Trading (algorithm suite with strategic-partner technology and transparent performance monitoring), and Outsourced Trading (an extension of clients' in-house execution strategy, workflow, technology, analytics, and regulatory compliance). Operates on a fully disclosed, agency-only basis with total anonymity in the marketplace.
- Consulting Services Asset-and-security-type-agnostic consultative offerings including Risk Management (liquidity, financing, balance sheet management, synthetic exposure, collateral optimization, regulatory guidance), Portfolio Solutions (portfolio construction, asset analysis, hedging, yield enhancement), Execution Consulting (total-cost-and-risk minimization using quantitative modeling), and Intelligence (bespoke macro-to-micro insights, impact studies, daily commentary).
- Capital Markets Investment banking and capital markets services including IPO Services, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, with over $1.5 billion raised in equity and debt capital. Specialty focus on small to medium-sized innovative Biotech, Pharmaceutical, Medtech, Diagnostic, and Telehealth companies, executed as bookrunner, co-bookrunner, sole placement agent, and underwriting roles.
Quantifiable outcome
- Over $1.5 billion in equity and debt capital raised for client companies
Companies that use WallachBeth Capital
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
WallachBeth Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
WallachBeth Capital partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Continental Stock Transfer & Trust CompanyminorProvided escrow services for SU Group Holdings public offering. Served as escrow agent in connection with registration rights and escrow agreements.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
WallachBeth Capital competitors and assessment
Company assessmentDirect peers
- EF Hutton: Boutique investment bank and broker-dealer with capital markets and institutional execution offerings. Comparable scale and target client profile, particularly on mid-market equity capital raises.
- Aegis Capital: Boutique broker-dealer providing institutional execution, research, and investment banking services. Comparable in size and institutional client focus.
- Loop Capital Markets: Boutique full-service broker-dealer and investment bank with institutional execution, capital markets, and advisory offerings. Comparable in size and service mix to WallachBeth across equities execution and mid-market IB.
- AtonRā: Boutique institutional broker specializing in equity execution and outsourced trading for asset managers. Directly comparable on the outsourced trading and agency execution proposition.
- Abel Noser Holdings: Boutique agency execution and trade analytics firm serving institutional asset managers and hedge funds. Closest like-for-like peer given similar agency-only positioning, focus on execution quality, and institutional client base.
- Maxim Group: Boutique broker-dealer and investment bank with strong focus on small/mid-cap healthcare and biotech capital markets. Directly comparable on the small-cap healthcare IPO and follow-on offering workflow.
- Rosenblatt Securities: Institutional broker-dealer with agency execution and capital markets capabilities serving hedge funds and asset managers. Comparable scale and structure, with overlapping execution and equity capital markets offerings.
Broad incumbents
- Instinet: Nomura-owned institutional broker-dealer with global agency execution and electronic trading. Overlaps with WallachBeth on equities execution and electronic trading, though at substantially greater scale.
- Liquidnet: Institutional trading network and execution venue for block equities and fixed income. Larger and more established, but comparable institutional client base and execution-focused product set.
- GTS: Electronic market maker and institutional execution provider operating a proprietary ATS. Larger scale and different model (principal), but competes for institutional equities and ETF execution flow.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
WallachBeth Capital social profiles
Digital presenceWallachBeth Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
WallachBeth Capital leadership team
Management profileNumber of profiles
Profiles10 records
WallachBeth Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
WallachBeth Capital M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about WallachBeth Capital
What does WallachBeth Capital do?
WallachBeth Capital is a boutique institutional broker-dealer providing execution, consulting, and capital markets services on a fully disclosed, agency-only basis. Its Execution practice delivers equities, ETF, and derivatives execution with algorithmic and outsourced trading capabilities for asset managers and hedge funds. Its Capital Markets practice provides investment banking services — IPOs, registered direct offerings, PIPE offerings, private placements, uplistings, bridge financing, and financial advisory — focused on small-to-mid-cap healthcare and biotech issuers, with over $1.5 billion in client capital raised.
Is WallachBeth Capital a public or private company?
WallachBeth Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was WallachBeth Capital founded?
WallachBeth Capital was founded in 2014. It employs 51 to 100 people.
Where is WallachBeth Capital based?
WallachBeth Capital is headquartered in New York, United States, in the North America region.
How does WallachBeth Capital make money?
Three revenue lines are on record. Capital Markets and Investment Banking Services are the primary driver. The others are institutional Execution Services and consulting Services.
Who are WallachBeth Capital's main competitors?
Direct peers on record are EF Hutton, Aegis Capital, Loop Capital Markets, AtonRā, Abel Noser Holdings, Maxim Group and Rosenblatt Securities. Broad incumbents are Instinet, Liquidnet and GTS.
Does WallachBeth Capital have an API?
No public API is recorded for WallachBeth Capital.
What industry is WallachBeth Capital in?
WallachBeth Capital's product category is Institutional Brokerage & Capital Markets. Its primary akta.pro industry code is FSACAFAA, Agency Equity Execution (Cash Equities), with a secondary code of FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked). Its NAICS code is 523150 and its SIC code is 6211.